Korea Gallup: "87% of Citizens Will Get COVID-19 Vaccination"
Countries around the world are racing to develop vaccines and treatments to overcome the novel coronavirus infection (COVID-19). Korean bio-venture company Engicam Life Sciences has received approval for a new drug substance from the U.S. Food and Drug Administration (FDA) and is conducting Phase 2 clinical trials. Ahead of the New Year 2021, a researcher is focusing on COVID-19 treatment research at Engicam Life Sciences Central Research Institute in Jecheon, Chungbuk. Photo by Jinhyung Kang aymsdream@
View original image[Asia Economy Reporter Hyunseok Yoo] It was found that 87% of our citizens are willing to receive the novel coronavirus infection (COVID-19) vaccine.
Korea Gallup announced on the 29th the 'COVID-19 Vaccine Vaccination Intention Survey Results' (with a 95% confidence level and a sampling error of ±2.5 percentage points).
This survey was conducted by Korea Gallup and WWS (WIN World Survey) member companies targeting citizens of a total of 32 countries.
In Korea, the survey was conducted through interviews with 1,500 people aged 19 and over from the 5th to the 29th of last month. 87% of the survey respondents said they would receive the COVID-19 vaccine, which is expected to be introduced soon. Specifically, 55% responded that they 'are likely to get vaccinated,' and 32% said they 'will definitely get vaccinated.'
On the other hand, 9% answered that they 'will not get vaccinated,' and 1% said they 'will never get vaccinated.' 3% of respondents either answered 'don't know' or refused to respond.
By age group, the response 'will definitely get vaccinated' was highest among those aged 60 and over at 43%, and lowest among those aged 19 to 29 at 23%.
The average intention to receive the COVID-19 vaccine among the 32 countries was about 71%. By country, Vietnam was the highest at 98%, followed by India and China (each 91%), Denmark and Korea (each 87%). Serbia was the lowest at 38%, with Croatia (41%) and France and Lebanon (each 44%) also showing low rates.
Meanwhile, in the global COVID-19 pandemic situation, the proportion of people who evaluated their government's crisis response as excellent was 82% in Korea.
Specifically, 15% of domestic survey respondents answered that the government's response was 'very excellent.' 67% responded that it was 'somewhat excellent.' 15.5% answered 'somewhat inadequate,' and 1.8% responded 'very inadequate.'
The rate of those who answered 'very excellent' was highest among people in their 40s and 50s at 18% each, followed by 15% in their 30s, 14% aged 60 and over, and lowest at 12% among those aged 19 to 29.
Among the 32 countries, an average of 52% evaluated their government's response as excellent, with Vietnam showing a unanimous positive response that the crisis response was well handled. China had 99%, and India had 87% positive evaluations.
Additionally, 88% of domestic survey respondents said that the national medical system is excellent in the COVID-19 situation. This is significantly higher than the average of 58% among the 32 countries.
Hot Picks Today
"South Korea Shows Similar Trend to Developed Nations"...Obesity Analysis of 232 Million People Worldwide [Reading Science]
- South Korea Overtakes Japan in a Decade: "This Time for Real"... Record-High Q1 Current Account Surplus Driven by Semiconductor Boom
- High-Net-Worth Investors Increase Stock Holdings: "Samsung and SK hynix Are Basic, Now Searching for the Next Opportunity" [Investment Strategies of the Wealthy] ⑧
- "You Don't Need to Go to the Gym": The Best Exercises for Lowering Hypertension
- "My Wife Is Missing"... Woman in Her 50s Still Unaccounted for Nearly a Month After Climbing Bukhansan Mountain
Regarding future prospects, only 14% of domestic respondents said that overseas travel would be possible next year. This is far below the average of 29% among the 32 countries. Also, only 6% of domestic respondents said that overseas business trips would be possible next year, the lowest among the 32 countries.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.